This progressive decline in beta cell function amidst a background of insulin resistance, which can be severe in many T2DM patients, particularly with the common concomitant presence of obesity, ultimately results in the need for high doses of insulin in many such patients. This evidence concerns the gene INS and type 2 diabetes mellitus.